Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 700 shares at $25.11 ($18K) on 2023-06-30, disclosed to the SEC on 2023-07-05.
Scheduled sale ($18k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |
| VIR | SELL | 2023-02-17 | $1.0M | — | Filing → |